Fasturtec - supply shortage

Resolved

rasburicase

Shortage information

The shortage affecting Fasturtec has been resolved and the information and recommendations which were issued during the shortage no longer apply.

Key facts

• Medicines affected:
  Fasturtec
• Supply shortage status:
  Resolved
• International non-proprietary name (INN) or common name:
  rasburicase
• Therapeutic area (MESH):
  Hyperuricemia
• Pharmaceutical forms affected:
  Powder and solvent for concentrate for solution for infusion
• Strengths affected:
  7.5 mg / 5 ml

Key dates

• Start of supply shortage:
  31/03/2023
• First published:
  21/02/2023
• Last updated:
  16/10/2025